LBX Pharmacy Chain
ISIN CNE1000023Q8
|WKN A2ACA5
Market cap (in EUR)
1,851.46 m
Country
China
Sector
Consumer Non-Cyclicals
Dividend yield
3.60%
Overview
Description
LBX Pharmacy Chain JSC is engaged in the sale of medicine and health products. Its business areas include Medicine retail, Medicine manufacturing, and Medicine wholesale. Its products include Chinese and Western medicine, traditional Chinese medicine, and non-medicine products. The company was founded by Zi Long Xie in 2001 and is headquartered in Changsha, China.
Consumer Non-Cyclicals Food and Staples Retail Health and Personal Care Retail China
Financials
Key metrics
| Market capitalisation, EUR | 1,851.46 m |
| EPS, EUR | 0.08 |
| P/B ratio | 2.21 |
| P/E ratio | 33.62 |
| Dividend yield | 3.60% |
Income statement (2024)
| Revenue, EUR | 2,862.01 m |
| Net income, EUR | 66.69 m |
| Profit margin | 2.33% |
What ETF is LBX Pharmacy Chain in?
There are 4 ETFs which contain LBX Pharmacy Chain. All of these ETFs are listed in the table below. The ETF with the largest weighting of LBX Pharmacy Chain is the Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
